Exome Analysis Identified Novel Homozygous Splice Site Donor Alteration in NT5C2 Gene in a Saudi Family Associated With Spastic Diplegia Cerebral Palsy, Developmental Delay, and Intellectual Disability

• Published in: Frontiers in genetics Vol. 11; p. 14
• Main Authors: Naseer, Muhammad Imran, Abdulkareem, Angham Abdulrahman, Pushparaj, Peter Natesan, Bibi, Fehmida, Chaudhary, Adeel G
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 21.02.2020
• Subjects: developmental delay; Genetics; microcephaly; NT5C2 gene; spastic diplegia; splice site mutation; microcephaly; developmental delay; spastic diplegia; splice site mutation; NT5C2 gene
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2020.00014

Hereditary spastic paraplegias (HSPs) is a rare heterogeneous group of neurodegenerative diseases, with upper and lower limb spasticity motor neuron disintegration leading to paraplegias. gene (OMIM: 600417) encode a hydrolase enzyme 5'-nucleotidase, cytosolic II play an important role in maintaining the balance of purine nucleotides and free nucleobases in the spinal cord and brain. In this study we have identified a large consanguineous Saudi family segregating a novel homozygous splice site donor alteration in gene leading to spastic diplegia cerebral palsy, developmental delay and microcephaly. Whole exome sequencing (WES) was performed for the affected members of the family to study the novel mutation. WES data analysis, confirmed by Sanger sequencing analysis, identifies a homozygous splice site donor alteration of possible interest in (ENST00000343289: c.539+1G > T) at the sixth exon/intron boundaries. The mutation was further ruled out in 100 healthy control from normal population. The novel homozygous mutation observed in this study has not been reported in the literature or variant databases. The identified splicing alteration broadens the mutation spectrum of gene in neurodevelopmental disorders. To the best of our knowledge this is the first report from Saudi Arabia.